Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model
- PMID: 17203207
Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model
Abstract
Responses of the liver to chronic injury include inflammation, regeneration and fibrosis, which finally lead to cirrhosis. The cause of liver cirrhosis appears to be impaired proliferative capability of hepatocytes caused by continuous hepatic damage, and subsequent accumulation of extracellular matrix produced by hepatic stellate cells (HSCs). Epidermal growth factor (EGF) and transforming growth factor-beta1 (TGF-beta1) play a crucial role in hepatocyte proliferation and hepatofibrogenesis, respectively. However, sequential analyses of the intrahepatic expression of EGF and TGF-beta1 in the course of cirrhosis development have not been examined fully. In the present study, liver cirrhosis was produced in rats by intraperitoneal administration of dimethylnitrosamine (DMN), and intrahepatic mRNA expression levels of proliferating cell nuclear antigen (PCNA), EGF and TGF-beta1 were quantitatively estimated by a real-time reverse transcription-polymerase chain reaction method. Histological and semiquantitative densitometric examination of liver sections revealed that the accumulation of extracellular matrix components was increased according to the period of DMN treatment. Histological examination of liver sections of rats treated with DMN for 4 and 6 weeks revealed pre-cirrhosis and cirrhosis, respectively. Intrahepatic mRNA expression levels of PCNA and EGF correlated well. Expression levels of both molecules were increased significantly during the course of cirrhosis development, but decreased significantly at the time of complete cirrhosis manifestation. In contrast, intrahepatic TGF-beta1 expression was increased significantly according to the period of DMN treatment, and reached a peak at the time of cirrhosis manifestation. These results suggest that proliferative capability of hepatocytes was impaired by continuous liver damage due, in part, to the decrease of a hepatocyte mitogen EGF, and that increased intrahepatic TGF-beta1 activated HSCs to retrieve space lost by hepatocyte destruction, resulting in complete cirrhosis manifestation.
Similar articles
-
Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.Int J Mol Med. 2006 May;17(5):857-64. Int J Mol Med. 2006. PMID: 16596271
-
Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis.Hepatology. 1997 Sep;26(3):624-33. doi: 10.1002/hep.510260314. Hepatology. 1997. PMID: 9303492
-
Proliferative capability of hepatocytes and expression of G1-related cell cycle molecules in the development of liver cirrhosis in rats.Int J Mol Med. 2004 Jun;13(6):779-87. Int J Mol Med. 2004. PMID: 15138612
-
Regulation of extracellular matrix remodeling following transforming growth factor-beta1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes.Cells Tissues Organs. 2007;185(1-3):116-22. doi: 10.1159/000101312. Cells Tissues Organs. 2007. PMID: 17587817 Review.
-
[The role of TGFbeta1 and IL-13 in cellular signal transduction of hepatic fibrosis of schistosomiasis].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2009 Aug;27(4):357-60. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2009. PMID: 20066997 Review. Chinese.
Cited by
-
A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.Gastroenterology. 2011 Jul;141(1):141-9. doi: 10.1053/j.gastro.2011.03.045. Epub 2011 Mar 24. Gastroenterology. 2011. PMID: 21440548 Free PMC article. Clinical Trial.
-
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.Hepatology. 2014 Apr;59(4):1577-90. doi: 10.1002/hep.26898. Epub 2014 Feb 28. Hepatology. 2014. PMID: 24677197 Free PMC article.
-
Preventative effect of Astragalus flavescens on hepatic fibrosis in rats and its mechanism of action.Exp Ther Med. 2013 Oct;6(4):904-908. doi: 10.3892/etm.2013.1232. Epub 2013 Jul 23. Exp Ther Med. 2013. PMID: 24137287 Free PMC article.
-
Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children.Pediatr Res. 2023 Oct;94(4):1297-1307. doi: 10.1038/s41390-023-02592-4. Epub 2023 May 3. Pediatr Res. 2023. PMID: 37138025
-
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.BMC Gastroenterol. 2010 Jul 9;10:79. doi: 10.1186/1471-230X-10-79. BMC Gastroenterol. 2010. PMID: 20618941 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous